ELOC and neoplasm: Considering a half of the tumor‐driven pVHL mutations harbor in α domain of pVHL, which interferes with its ability to bind elongin C and leads to the loss of pVHL protein stability,[14, 41, 42] we propose that OTUD6B overexpression resists HIF‐1α accumulation in tumor cells with pVHL α domain mutations.